Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE)

PERUSE investigators

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE)'. Together they form a unique fingerprint.

Medicine & Life Sciences